RecruitingNot ApplicableNCT06902662

Sanghuangporus Sanghuang Supplementation to Improve Anti-Fatigue Performance in Healthy Adults

Clinical Evaluation of Sanghuangporus Sanghuang in Anti-fatigue


Sponsor

National Taiwan Sport University

Enrollment

60 participants

Start Date

Apr 7, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical study aims to evaluate the anti-fatigue and muscle performance-enhancing effects of Sanghuangporus sanghuang mycelia (SS-MN4) capsules in healthy adults. As muscle mass and function naturally decline with age or sedentary lifestyle, there is growing interest in nutritional interventions that may help preserve physical performance and reduce fatigue. Sanghuangporus sanghuang, a traditional medicinal fungus, contains bioactive compounds such as hispidin, known for their antioxidant and anti-inflammatory properties. The study is a randomized, double-blind, placebo-controlled trial involving 60 healthy male participants aged 20 to 35 years with no regular exercise habits. Participants will be randomly assigned to receive either SS-MN4 capsules (1000 mg/day) or a placebo for 42 days. The intervention aims to determine whether SS-MN4 improves exercise performance, muscle strength, and biochemical markers related to fatigue and muscle damage. Throughout the study, blood samples, urine samples, exercise tests (e.g., anaerobic power, isometric strength), and body composition analyses (DEXA) will be conducted at multiple time points, including before, during, and after the intervention. In addition, intestinal microbiota analysis and nutritional intake records will be included to assess secondary outcomes. This research will provide scientific evidence for the health benefits of SS-MN4 in reducing exercise-induced fatigue and improving muscle function. The data collected may support future applications for anti-fatigue health food certification in Taiwan and the development of novel functional supplements for global markets.


Eligibility

Sex: MALEMin Age: 20 YearsMax Age: 35 Years

Inclusion Criteria7

  • Healthy male participants aged between 20 and 35 years
  • Non-smokers and non-drinkers
  • Not currently taking any dietary supplements or medications
  • Normal liver and kidney function
  • No chronic diseases such as cardiovascular disease
  • Willing and able to provide written informed consent
  • Able to comply with study procedures and schedule

Exclusion Criteria7

  • Current or past diagnosis of any cardiovascular, liver, kidney, or metabolic disease
  • Regular use of dietary supplements, sports nutrition products, or energy drinks
  • Known food allergies or intolerances, particularly to mushrooms or herbal products
  • Engaging in regular resistance or endurance training in the last 6 months
  • Currently taking medications that may interfere with study outcomes
  • Smoking or alcohol consumption
  • Participation in other clinical trials within the last 3 months

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTSS-MN4

Participants in the SS-MN4 group will take 2 capsules daily containing a total of 1000 mg/day of Sanghuangporus sanghuang mycelia extract for 42 consecutive days. The capsules are identical in appearance to the placebo.

DIETARY_SUPPLEMENTPlacebo

Participants in the placebo group will take 2 capsules daily of an inert substance designed to match the SS-MN4 capsules in color, taste, and appearance. The placebo contains no active ingredients and will be taken for 42 consecutive days.


Locations(1)

National Taiwan Sport University, Graduate Institute of Sports Science

Taoyuan District, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06902662


Related Trials